1Nishmura M, Mizuta I, Mizuta E, et al. Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease [J].Neurosci Lett, 2001, 311 (1): 1 - 4.
2Bayley JP, de Rooij H, Van den Elsen PJ, et al. Functional analysis of linker-scan mutants spanning the -376,-308,-244, and -238 polymorphic sites of the TNF-alpha promoter [J]. Cytoking, 2001, 14(6) ;316 - 323.
3Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis [J].Annu Rev Immunol, 1995,13:29 - 60.
4Interleukin-1 beta or tumornecrosis factor-alpha on hepatitis B virus enhancer activity[J]. Biochem Biophys Res Commun, 1992, 183(2):904 - 990.
5T Hohle, A Kruger, G Gerken, et al. A tumor necrosis factor-alpha(TNF-α) promoter polymorphism is associated with chronic hepatitis B infection[J]. Clin Exp Immunol, 1998, 111:579 - 582.
6Frederick M Ausubol, Rozer Brent, Robert Ekingston. Current Protocols in molecular Biology[M]. Supplement USA:John Wley Sons,Inc, 1995, 2.91 - 2.9.11.
7Hajeer AH, Hutchinson. Influence of TNF-alpha gene polymorphisms on TNF-alpha production and disease[J]. Hum Immunol,201, 62(11) : 1191 - 1199.
8Rinkman BM, uizinga TW, Kurban SS, et al. Tumout necrosis factor alpha gene polymorphisms in rheumatoid arthritis; association with susceptibility to, or severity of, disease[J]. Br J Rheumatol, 1997, 36(5) :516 - 521.
9Bayley JP, de Rooij H, Van den Elsen PJ, et al. Functional analysis of mutants panning the -376,-308,-244, and -238 polymorphic sites of the TNF-alpha promoter[J]. Cytokine, 2001, 14(6) :316 - 323.
